InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-18.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Zago Wagner M., Directeur Scientifique. Insider active across 1 company, notably Prothena CORP Public Ltd Co. In total, 5 disclosures have been logged. Activity tracked since 22 June 2021. The latest transaction was disclosed on 2 August 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
4,000 shares@ US$12.154.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-037713:0
4,000 shares@ US$12.154.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-033192:0
15,000 shares@ US$29.8141.2% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-028870:0
15,000 shares@ US$20.1725.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-012571
15,000 shares@ US$20.170.049% mcap50.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-012571:0
5 of 5 declarations
About Zago Wagner M.
Zago Wagner M. is the Chief Scientific Officer at Prothena Corp Public Ltd Co. In this role, he oversees research and the development of new treatments. His scientific expertise is crucial for innovation and advancing the company's projects.
